|
Dr. Joseph P. Miletich, MD, PhD
Joseph
P. Miletich, M.D, Ph.D. is Senior
Vice President, Research and
Development at Amgen, Inc. where he
created and leads the company’s
innovative Translational Sciences
organization. This critical part of
Amgen’s R&D efforts unlocks the
promise of early discoveries by
demonstrating their potential to
alter disease in a beneficial way.
Dr. Miletich joined Amgen from Merck
Research Laboratories where he was
Senior Vice President, Worldwide
Pre-clinical Development. Before
joining Merck, Dr. Miletich was
Professor of Internal Medicine and
Pathology at the Washington
University School of Medicine in St.
Louis and he held the additional
position of Chief of the Division of
Laboratory Medicine. He also served
as Director of Laboratories at
Barnes-Jewish Hospital in St. Louis.
Dr. Miletich received his M.D. and
Ph.D. in molecular biology from
Washington University in St. Louis
and trained in internal medicine at
the University of California, San
Francisco. He has authored numerous
peer-reviewed manuscripts in the
field of hematology and pathology
and has served with distinction on
expert scientific review groups and
editorial boards. |
